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ABSTRACT 
Purpose: The purpose of this study was to identify factors that correlate 
with medication non-adherence in teens diagnosed with juvenile arthritis.  
Background: The impact of medication non-adherence often begins in 
childhood where children depend and learn from their care-givers how to manage 
their health. Children with chronic disorders are among those at risk for a higher 
medication non-adherence. Juvenile arthritis (JA) is a chronic childhood disorder 
where often medication non-adherence is an issue.   
Methodology: This was a mixed-method qualitative and quantitative pilot 
study. Teens between the ages of 11 – 17 years, with juvenile arthritis were asked 
to volunteer in this study. Their medication adherence score were measured 
utilizing a Modified Medication Adherence Scale (MMAS). The second survey 
was to assess the patient’s knowledge of their medication and was called the open-
ended questionnaire. Fisher’s exact test was used to determine if there was a 
statistical relationship between age, gender and ethnicity with their Modified 
Medication Adherence Score (MMAS). Knowledge comprehension of their 
medication’s action was then compared to medication adherence scores.  
Results: Results varied as some patients scored lowered on their MMAS, 
but were knowledgeable about the action of their medication. The highest factor 
for all age groups, genders and ethnicity were forgetfulness. There were inherent 
limitations in this study as results were varied, subjective and skewed.  
Conclusions: Based on this study, teens between the ages of 16-17 years of 
age scored higher in medication adherence. Gender and ethnicity were not shown 
to have a statistical relationship in their medication adherence scores.  
Forgetfulness was the common factor identified in medication non-adherence, 
while medication knowledge was not a factor in medication adherence scores. 
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CHAPTER 1: INTRODUCTION 
Background 
The effect of medication non-adherence in this country is profound. A 
report from the World Health Organization (2011) found that in the United States 
an estimated one-thirds to two-thirds of the adult population do not take 
medication on a regular basis. This lack of medication adherence results in 
increased hospitalizations and disease processes that are preventable. A report 
from the World Health Organization, for the year 2010 in the United States, 
estimated the cost of medication non-adherence for adults and pediatrics to be over 
$100 billion annually (Osterberg & Blashcke, 2003).  
Medication adherence is an issue that touches patients of all races, ages, 
and social demographics (Rapoff, 2002). Children depend on their caregivers to 
obtain their medications for them, as well as to help them remember to take it 
consistently. Children tend to develop certain beliefs and views on medication and 
health care from their family. For every stage of child development, there is a 
common reason for children not adhering to their medication. In toddlers, this 
common reason is taste, which can be remedied by flavored syrups (Marla, Lussler 
& Bacar, 2011). In school-age children, forgetfulness is a common factor; 
calendars and journaling can help these children keep track of when to take their 
medications. Teens, who are at a risk-taking age, may take the chance of choosing 
alternative modes of medication or no medications at all (Gauthier & Cardot, 
2012). These types of behaviors, if not corrected at a young age, may lead to 
future non-adherent adults.  
Children diagnosed with juvenile arthritis (JA) experience joint 
inflammation and pain. If not treated, these children may have difficulty with gait 
and mobility, and some may need assistive devices in order to help with 
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movement. These children are prescribed medications over a long period of time, 
which often have undesirable side effects (SE) and prolonged therapeutic effects 
(Rapoff, 2002).  
The first choice for treatment of JA is methotrexate (MTX). MTX is a 
chronic disease-modifying antirheumatic drug that has been shown to improve 
physiological and psychological effects of JA (Hahn & Kim, 2010). The most 
common recognized side effects of MTX are gastrointestinal, including nausea 
and vomiting (Klein et al., 2012). Mulligan et al. (2013) stated in their study that 
“a child who experiences nausea and vomiting, will develop anticipatory nausea 
(symptoms occurring before the medication is taken) and reluctance to take MTX 
may develop” (p.1). In an effort to decrease the side effects of MTX, injections of 
MTX can be given, but fear of injections and monthly monitoring of blood tests 
may decrease adherence to treatment (Mulligan et al., 2013).  
Adherence to long-term treatment is a challenge for many patients with 
chronic diseases. In the last two decades, there has been an increase in studies on 
medication non-adherence in pediatrics with ADHD, asthma, diabetes, and JA 
(Hanghoj & Boisen, 2013; Marla et al., 2011). These studies showed that many 
factors contributed to medication non-adherence in patients, including finances, 
cultural beliefs, lack of insurance, lack of consistent health care, and forgetfulness 
from the patient or parent (Matsui, 2013). Research has begun on ways to increase 
pediatric adherence. This may include simplifying the medication routine, 
increasing adherence by electronic reminders, or even changing the way a 
medication tastes or is administered (Gardiner & Dvorkin, 2006).  
The purpose of this study is to see if there is a relationship between age, 
gender, and ethnicity with medication adherence scores among teens diagnosed 
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with JA. This study also measures the correlation, if any, between patients’ 
understanding of their medication and their medication adherence scores.  
The survey I used to measure medication adherence was the Modified 
Morisky Medication Adherence Scale (MMAS). I chose this survey because it was 
easy for pediatric patients to read, complete, and understand. The questions were 
formulated to be answered in “yes” or “no” formats, and the final question uses a 
five-point Likert Scale to assess the amount of difficulty patients have 
remembering to take their medication. The MMAS measures factors such as 
patient forgetfulness, medication side effects, and convenience of medication 
regimen (Morisky & DiMatteo, 2011). Additionally, in order to assess 
participants’ knowledge of their medication, I supplemented the MMAS survey 
with an open-ended questionnaire.  
Theoretical Framework 
Goal Attainment Theory 
Imogene King’s Theory of Goal Attainment is the metaparadigm theory 
that will provide the framework for this study. This theory takes into account the 
intrinsic and extrinsic factors that can help patients obtain particular healthcare 
goals. This theory also describes the nurse-client relationship in helping the patient 
achieve their optimal health goal (Alligood, 2014).  
 King’s Theory of Goal Attainment can be summarized as a process of 
continuous and dynamic interaction between the nurse and the client. This 
interaction can happen through verbal or nonverbal communication; its purpose is 
to allow the nurse and patient to set common goals for the patient’s care, based on 
their shared perception of the patient’s situation (Alligood, 2014). This system 
emphasizes the importance of collaboration between the nurse and patient.  
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There are five key concepts comprising King’s Theory of Goal Attainment: 
interaction, communication, transaction, role, and stress. The following is a 
summary of these five concepts. 
 Interaction—the verbal and nonverbal behavior of two or more persons 
in mutual presence, directed towards some goal. 
 Communication—the means by which human relations are developed 
and maintained. This includes intrapersonal, interpersonal, verbal, and 
nonverbal communication. 
 Transaction—a process of interaction in which human beings 
communicate with the environment to achieve goals that are valued; 
goal-directed human behaviors. 
 Role—a set of behaviors expected of a person occupying a position in a 
social system. 
 Stress—a dynamic state whereby a human being interacts with the 
environment to maintain balance for growth, development, and 
performance, involving an exchange of energy and information between 
the person and the environment for regulation and control of stressors. 
 Coping—a way of dealing with stress. (Alligood, 2014). 
Parts of King’s Goal Attainment Theory originated from her Interacting 
Systems Framework, describing the interactions and transactions between 
healthcare provider and patient. In King’s Goal Attainment Theory, the nurse and 
patient mutually set goals and work to achieve them through a series of 
interactions and transactions. In this framework, both parties have a purpose; they 
perceive, judge, act and react upon each other. At the end of their communication, 
a goal will be set and with this the transactions are made. King believed that the 
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goal of nursing “is to help individuals maintain their health so they can function in 
their roles” (Alligood, 2014, p. 312). 
These interactions between the nurse, client and outside stressors are the 
keys to medication compliance. It is the role of the nurse or care provider to 
educate and follow up on the patient’s home treatment. Among younger patients, 
the patient’s family is the primary factor in determining whether or not a child will 
comply with their home health routine. However, extrinsic factors such as health 
care accessibility, insurance, and financial stability also play a role in this 
situation.  
King stated that nursing's focus is on the care of the patient, and its goal is 
the health care of patients and groups of patients (as cited in Alligood, 2014, p. 
24). The goal of increasing medication adherence is achievable through patient 
education and simplifying a child’s medication routine. An important aspect of 
increasing medication adherence is increasing patient knowledge, not only for the 
patient but for the family.  
The Teach Back Method 
One way to increase patient knowledge of how to properly take their 
medication is through the teach-back method. The teach-back method is a way to 
educate patients by having the patients use their own words to restate what they 
had been taught by their healthcare providers. This method has been implemented 
in clinical and outpatient settings in over the last decade, as a tool in assessing how 
much of the healthcare information given by his or her provider the patient has 
retained (Xu, 2012). 
 
 




Figure 1. Teach Back Theory Model from Schillinger, D. et al (2003), p. 84 
Orem’s Self-Care Deficit Theory 
Orem’s general theory of nursing is based on three interrelated theories: the 
theory of self-care, the theory of self-care deficit, and the theory of nursing system 
(Cox & Taylor, 2005). In this framework, the theory self-care deficit specifies 
when nursing is needed. According to Orem, nursing is required when an 
individual is incapable or limited in his or her ability to provide continuous, 
effective self-care. Orem identifies five methods of helping individuals provide 
self-care: actively performing self-care tasks for the individual; guiding the 
individual; supporting the individual; providing an environment promoting 
personal development; and teaching the individual (as cited in Cox & Taylor, 
2005). This reinforces the principle of the nurses helping patients by enabling 
patients care for themselves through patient education. Such care includes 
assessments on the part of the nurse as to how to simplify patients’ medication 
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routines in order to promote medication adherence. In this way, nurses can help 
guide patients towards independent self-care, in accordance with Orem’s theory. 
Unifying Theoretical Themes  
King’s Goal Attainment Theory and Orem’s Self-Care Deficit Theory both 
focus on patients’ ability to manage their own health care. They emphasize the 
role of healthcare providers in determining whether or not patients can effectively 
provide self-care, which includes adherence to their healthcare and medication 
routines. The unifying goal is patient knowledge and patient education. The ability 
to understand the importance of their medication and how to properly use it is a 
factor in whether or not a client will adhere to their medication. King’s and 
Orem’s theories unifying theme is patient’s self-care through knowledge and goal 
setting. 
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CHAPTER 2: LITERATURE REVIEW 
Juvenile arthritis is an autoimmune disease that affects nearly 250,000 
children under the age of 16 each year (American Academy of Orthopedic 
Surgeons [AAOS], 2014). The physical side effects of JA include joint 
inflammation, joint contractures, and joint damage, pain, and growth abnormalities 
in children (AAOS, 2014; Bechtold & Simon, 2014). It is crucial to identify such 
conditions early on and implement appropriate treatment; poor management of 
juvenile arthritis in childhood and adolescence can lead to ineffective management 
in adulthood (Hanghoj & Boisen, 2013).  
Definitions 
Non-compliance has often been used to describe patients’ refusal or 
inability to follow their medication or health regimens at home (Matsui, 2013). 
The term non-compliance has negative connotations, suggesting that patients do 
not want to follow, or comply, with their healthcare. Therefore, this term has been 
replaced with non-adherence in current healthcare writing (Delamer, 2006).  
To date, measurement of patient medication adherence and use of 
interventions to improve adherence is not commonly practiced in routine clinical 
practice and acute care settings. For this reason, medication adherence has been 
called the “next frontier in quality improvement” and has become an important 
aspect of patient health care and initiatives (Heidenrich, 2004).  
It should also be noted that the term juvenile arthritis (JA) is used 
throughout this study to refer interchangeably to juvenile rheumatoid arthritis and 
juvenile idiopathic arthritis. 
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Reasons for Medication Non-Adherence in Teens 
Diagnosed with JA 
Adherence to long-term treatments is a challenge for many pediatric 
patients diagnosed with chronic diseases (Feldman et al., 2007). Medication 
adherence may be influenced by a number of factors intrinsic or extrinsic to the 
individual: these factors can include the individual’s cultural upbringing, personal 
values and ideas (intrinsic); or may involve environmental, financial, and family 
dynamics, as well as external stressors that influence the patient’s health care 
beliefs (Brown & Bussell, 2011). Families play an important role in medication 
adherence.  Children are dependent on their guardians for following up on their 
medication, refilling prescriptions, and, in the case of younger children, 
administering medication.  
Social demographics may play a part in treatment non-adherence. Studies 
of treatment adherence among patients diagnosed with JA reveal higher rates of 
adherence among patients from families with higher socioeconomic status (Rapoff 
et al., 2002). Economic factors influence whether or not a patient is able to adhere 
to such aspects of treatment as paying for medication, medical appointments and 
follow-ups, transportation to and from appointments, and health insurance (Rapoff 
et al., 2002). The families of children with chronic disorders may be burdened 
with economic issues. This may lead parents to omit their children’s doses, split 
tablets to make them last longer, or delay refilling prescriptions (Matsui, 2013). 
An on-line community survey done by Laba, Brien and Jan (2012) found that out-
of-pocket drug costs had a significant influence on whether or not patients 
continued with a medication. Other research, primarily from the United States, has 
shown that cost-related medication non-adherence is widespread (Law et al., 
2012).   
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Patient-reported rates of cost-related underuse of medications ranged from 
1.6% to 22% in survey studies (Kirking et al., 2006). Briesacher, Gurwitz, and 
Soumerai found that not having prescription drug coverage was a significant risk 
factor for cost-related medication underuse (2007). Lack of insurance for 
prescription medications was associated with a more than fourfold increase in the 
chance of non-adherence (Law et al., 2012). Patients’ country of residence may 
also play a role in medication non-adherence. For example, patients in the United 
States have been found to be between two and three times more likely to report 
cost-related non-adherence than Canadian residents (Viswanthan, Golin, & Jones, 
2012). Identifying factors contributing to cost-related medication non-adherence 
may facilitate the development of strategies to reduce cost-related burdens for 
patients.  
However, cost-related factors are not the only predictors of non-adherence. 
Medication non-adherence may stem from factors that include the family’s health 
beliefs, the side effects of the medications, and the frequency with which the 
medication must be administered (Briesacher, Gurwitz, & Soumerai, 2007). 
Access to medication is another aspect that must be considered, and its 
relevance increases with each increase in the cost of treatment. Pelajo et al. 
assessed adherence to methotrexate among 76 children from two centers in two 
socioeconomically contrasting locations. The study showed poor adherence in 
18% of patients. Among children in the Rio de Janeiro location, which had the 
lower average socioeconomic level, the difficulty of obtaining medication was the 
main cause of poor adherence. Among the children in Boston, which had the 
higher average socioeconomic level, the main cause of poor adherence was the 
child’s refusal to take the medication (Pelajo et al., 2012). 
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Studies have shown higher adherence to medication in those environments 
with a better family structure and among patients with chronic diseases (Matsui, 
2013; Rapoff, 2006 and Viswanthan et al., 2012). Families, or caregivers, whose 
child may be newly diagnosed with JA experience an increase in emotional stress 
which may contribute to decreased medication adherence. Mulligan et al. (2013) 
assessed the psychological stress and quality of life of 40 caregivers of JA 
patients. That study found caregivers who were female, single, and caring for 
patients with polyarticular JA to be most affected by stress and least likely to 
adhere to their child’s medication regimen (Mulligan et al., 2013).  
Not all caregivers can fully manage caring for children with chronic 
diseases, which often requires complex regimens of administering several 
medications a day and carrying out time-consuming non-drug treatments that 
require an organized schedule. In 2013, Mulligan et al. studied mothers’ views of 
difficulties that children with JA experienced while taking MTX . They formulated 
a questionnaire for the mothers about the medication MTX, but the children 
themselves were not surveyed. This study found that the majority of mothers 
(68%) reported improved physical symptoms for their child while on MTX. More 
than half of the children taking MTX, reported nausea and vomiting before and 
after subcutaneous, as opposed to oral, administration of the medication. Feeling 
sick and anxiety over blood draws were the common complaints reported in this 
study (Mulligan et al., 2013).  
There is additional risk of non-adherence in adolescents and young adults 
with JA. This population may have difficulties with self-management, particularly 
during the transition to adulthood. Lawson et al. (2011) administered a cross-
sectional survey to teens between the ages of 13 and 20. This study found that the 
main reason for missing their medication was forgetfulness. Other barriers 
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reported from this sample: inability to fill prescriptions, schedule appointments, 
arrange transportation to and from appointments, ask questions, recognize relevant 
signs and symptoms, or manage healthcare-related finances and insurance. This 
resulted in a lowered prognosis for this age group, due to their lack of training in 
organizational and self-management skills related to their own healthcare (Lawson 
et al., 2011).  This potential lack of self-management ability among teen patients 
and their caregivers may reduce teens’ adherence to medical treatment (Claudio, 
Miotto, & Terreri, 2014).  
Lawson et al. suggested potential solutions to these self-reported barriers to 
care among teens. These potential solutions included encouraging older 
adolescents to become pro-actively involved in their own health care, as well as 
patient education modified for children. They also suggested helping younger 
patients establish calendars for their medications and medical appointments 
(Lawson et al., 2011). Unless solutions can be found that will teach children and 
adolescents effective ways to manage their medications and medical treatment 
plan, we may be raising future adults who will continue to be non-adherent to their 
medications and plan of care.    
The complexity of the therapeutic regimen also plays a factor in medication 
adherence in drug treatment. Claudio et al. (2014) revealed poorer adherence to 
medication when the regimen consisted of more than three daily drugs. There is 
also lower adherence to immunosuppressive medications and disease modifiers 
(Bugni et al., 2012). 
Research has also pointed to common reasons for medication non-
adherence particular to individual stages in children’s development. For example, 
the main reason for medication non-adherence in toddlers tends to be taste; for 
school-aged children, the main reason tends to be forgetfulness. Meanwhile, teens, 
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who are at an age for risk-taking, may choose not to take their medications or 
follow through with medical treatment (Gardiner & Dvorkin, 2006).  
The presence of unwanted side effects in drugs used in the treatment of 
JA—particularly NSAIDs, methotrexate, lefunomide, corticosteroids, biological 
drugs and immunosupressive agents—also increases non-adherence. The presence 
of side effects may lead the patient to refuse the drug because of a fear of 
worsening his or her condition (Pelajo et al., 2012).  
Lack of knowledge about the disease process is also an important factor 
that can lead to non-adherence. Patients and their families may be unfamiliar with  
their medications’ delayed therapeutic effects or be confused by unwanted side 
effects. This can lead to patients refusing to take the drugs; it can also lead to 
patients stopping non-drug treatments, such as physiotherapy and the use of 
orthoses (Pelajo et al., 2012; Bugni et al., 2012, April, Ehrmann-Feldman, Platt, & 
Duffy, 2006).  
Finally, the relationship between the patient and their healthcare provider 
also plays a part in medication adherence. Iwamoto et al. observed that lack of 
structure related to healthcare, difficulty in obtaining medication, and difficulty 
seeing the healthcare provider can be major psychological stressors for caregivers 
of JA patients (2008). Studies evaluating the main factors associated with 
satisfaction or dissatisfaction with healthcare services found a significant 
correlation between patient satisfaction with their healthcare team, and improved 
adherence to treatment and lower probability of switching providers (Costello, 
Wong, & Nunn, 2006).  
In 2011, the American College of Preventative Medicine created the 
following summary of common factors in medication non-adherence among 
children with chronic diseases, including juvenile arthritis:  
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 Low literacy 
 Forgetfullness 
 Psychological stress or anxiety 
 Lack of insight into illness 
 Lack of belief in benefit of treatment 
 Cultural incongruenccy 
 Belief medication is not important or harmful 
 Inconvenience of medication regimen 
 Side effects or fear of side effects 
 Cost of medication or co-payment 
 Barriers to access to care or medication 
 Inadequate follow-up 
 Missed appointments  
Studies of pediatric medication non-adherence often interview the parents 
of the children receiving medication versus the children themselves (Mulligan et 
al., 2013). In reviewing the literature, I have found few articles in which the 
children or teens with JA were, themselves, surveyed about their medications. Nor 
are there any studies on assessing a child’s knowledge of their medication and its 
effects on their medication non-adherence. This study will look at whether there is 
a relationship between age, gender and ethnicity with medication non- adherence. 
This study will also see if there is a positive correlation between teen’s knowledge 
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 CHAPTER 3: METHODOLOGY 
Project Survey Methods 
The methodology for this pilot study used quantitative and qualitative 
methods, with correlational analysis. The quantitative methods used to determine 
if there was a statistical relationship between age, gender and ethnicity in relation 
to medication adherence (MMAS) scores was the Fisher’s exact test. The 
qualitative portion looked at the subject’s response in assessing knowledge of their 
medication in relation to their medication adherence score. The investigator 
administered the MMAS in order to measure medication adherence scores for the 
subjects tested. The second survey, administered with the MMAS, was the open-
ended questionnaire. This measured knowledge of the patient’s medication as well 
as alternative methods used to help their JA symptoms. 
Setting 
This study took place in a pediatric outpatient rheumatology clinic in the 
Central Valley between November, 2014 and January, 2015. Subjects were 
recruited on a voluntary basis. After their outpatient visit, subjects were asked if 
they would like to participate in this study. 
Population Sample 
Inclusive criteria for the subjects recruited for this study were: between the 
ages of 11–17 years, English-speaking, diagnosed with JA for a minimum of one 
year and only diagnosed with JA. The surveys were handed to 50 subjects, of 
whom 37 subjects volunteered to be part of the study. Out of the 37 subjects who 
completed the survey, 26 surveys were actually used. Eleven surveys were omitted 
due to parental involvement or incompletion. Thorough explanation was done for 
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the patients and their parents and consents and assents were obtained. This was to 
ensure the subjects understood participation in the study was voluntary, and that 
their health providers would not see their results. After the children’s assents, and 
parents’ consent, explanations were done on the survey itself and time was given 
for the subjects to complete their survey and questionnaire with the investigators 
in the room. If the child was nervous or had questions about the survey, directions 
were provided to the child and questions were answered while the investigators 
were in the room.  
During the administration of these MMAS surveys and open-ended 
questionnaires confidentiality was maintained. The names of the subjects were not 
written on the surveys itself. Data was summarized by subject numbers to ensure 
patient confidentiality. Patients and their families were instructed of this. IRB 
approval was obtained through the children’s hospital site before the study began. 
Instrumentation 
Two surveys were administered for those participants who chose to consent 
to this study. The first survey was the MMAS survey, which is found in appendix 
D. The second survey asked patients open-ended questions such as knowledge of 
their medication, as well as what other activities they do to help with their JA 
symptoms. In addition, the open-ended questionnaire asks about participants’ 
social demographics such as age, gender, ethnicity, and years diagnosed with JA. 
Data Analysis 
The survey tool used for this study was the Morisky Medication Adherence 
Scale (MMAS-8 Item). Questions 1–7 of the MMAS ask whether or not 
respondents ever forget to take medication, stop medication if side effects occurs, 
stopping medications when they don’t experience symptoms from their JA, and 
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whether or not they feel inconvenienced by having to take their medication on a 
regular basis. These are “yes” or “no” questions. Question 8 of the MMAS asks 
participants to rate the difficulty of remembering to take one’s medication, based 
on a Likert scale from 0–4. The possible responses for Question 8 are: 4 = 
Never/Rarely forgetting to take one’s medication, 3 = Once in a while forgetting, 2 
= Sometimes forgetting, 1 = Usually forgetting, and 0 = All the time forgetting to 
take medication.   
The responses from 26 surveys were collected, coded, and given an 
adherence scale of 0–8. Low adherence were those scores <6, medium adherence 
are those scores from 6–7, and high adherence are those scores of 8.  Specific 
coding instructions for the Morisky Medication Adherence Scale are clearly 
identified in the MMAS information sheet. 
The results of the MMAS were calculated based on the percentage of yes 
and no questions for the first seven questions. The remaining question, which had 
five responses, was accounted for in the final calculations based on the 
percentages of each response. After medication adherence scores were calculated, 
Fisher’s exact test was used to determine if there was a statistical relationship 
between age, gender and ethnicity in relation to medication adherence scores.   
The remaining two questions were qualitative in nature as it was determined if 
knowledge of the subject’s medication affects medication adherence scores. 
Precautions Taken to Minimize Risks 
No names or identifying factors were included on the survey itself. Written 
consent by the participants, the patient and their parents was obtained, and none of 
the signed consent and assent forms could link the participant to the surveys. A 
small sticker was placed inside the file, or electronic tag, of the individuals who 
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were surveyed. This was to track those pediatric patients who had been asked to 
take part in this study.  
Once the surveys were completed they were entered in a secured electronic 
file, only accessible to the primary investigator. Assents and consents were entered 
separately into a secured file at the rheumatology clinic.  Data results were only 
interpreted by the primary investigator. All hard copies of the surveys, assents, and 
consents were shredded and disposed of properly once the study was complete. 
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CHAPTER 4: RESULTS 
Reviewing all subjects (n=26) in their responses to their MMAS survey, the 
highest response was to Question 1. The questions asked, “How often do you 
forget to take your medication?” The percentage of subjects who answered “yes” 
to this question was 93%. This was the highest percentage measured based on all 8 
questions from the MMAS. The second highest percentage of “yes” answers 
(83%) was to Question 5. This question asked participants, “Did they take their 
medications yesterday?” The lowest percentage of “yes” responses (19%) was to 
Question 3, which asked, “Have you ever cut back or stop, without telling your 
doctor, because you felt worse when you took it?” This question also indirectly 
measured the effects of side effects from their medications, suggesting that even if 
the subjects experiencing side effects would not discontinue their medications. 
The final question asked, “How often do you have difficulty remembering to take 
all your medications?” The response was based on a 5-point Likert Scale with 
subjects answering 15% to “Never,” 54% response to “Once in a while,” 23% 
answered “Sometimes,” 8% answered “Usually” and 0 subjects answered “All the 
time.” The majority of subjects (54%) responded that “Once in while” they would 
forget to take their medication. Similarly to Question 1, this question measures 
forgetfulness. 
In measuring adherence using the MMAS, a score of = 8 is high adherence, 
a score of 6-7 = moderate adherence, and < 6 = low adherence. Of those tested, 1 
subject scored high adherence, 8 subjects scored moderate adherence, and 17 
subjects scored low adherence.  The average MMAS adherence score was 
4.75692. The median score was 4.75.  
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Figure 2. Responses to MMAS Survey Questions 1–7 (percent of participants) 
 
Figure 3. Responses to MMAS Survey Questions 8 (percent of participants) 
Statistical analysis used was Fisher’s exact test. It was used due to our 
small sample size; and, to determine if there were any statistical relationships 
between age, gender and ethnicity with medication adherence (MMAS) scores.  In 
determining correlation between ethnicity and MMAS, based on Fishers exact test 
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(p ~ 1) there was no statistical relationship. In determining correlation between 
gender and MMAS scores, based on Fishers exact test (p = 0.336), there was no 
significant statistical relationship.  Therefore, based on this study, there was no 
statistical relationship with ethnicity and gender in relation to medication (MMAS) 
adherence scores. 
 In this study, there was a statistical relationship between the age of the 
subject and their adherence score. Older patients were more adherent than younger 
patients tested. The average age of the subject was 16.88 for a high adherence 
score. The average age for a moderate score was 14.76. The low adherence score’s 
average age was 14.86. The probability of a child being older in age, over the age 
of 16, correlated with a higher adherence score. [Refer to table 3.]   
In comparing the subject’s knowledge of their medication to their MMAS 
score, the responses varied. The subject who scored a high adherence score 
(MMAS = 8) answered, “Actemera” as what her medication does. Therefore, this 
subject had low medication knowledge, but a high medication adherence score. 
Subjects who scored a moderate adherence score (MMAS = 6-7) had appropriate 
knowledge of their medication. Subject’s responses to describing what their 
medication does to help their JA were: “Reduces inflammation and targets certain 
proteins in my body that don’t respond properly.” Another subject answered “It 
helps my joint to move better and not swell up.” Those subjects who scored the 
lowest MMAS scores (MMAS <5) also had appropriate medication knowledge. 
Subjects who scored low medication adherence score (MMAS = 1 to 2) responses 
were: “Some medication helps stop the inflammation in my joints and also to help 
with the pain” and “Helps slow down the swelling.” Therefore, based on this pilot 
study, we can conclude that a subject’s knowledge of their medication does not 
correlate with higher medication adherence.   
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Table 1. MMAS Scores by Ethnicity: Number of Respondents with High, 
Medium, and Low Scores 
Ethnicity High Score (8) Med Score (6–7) Low Score (<5) 
Hispanic 3 3 3 
White 2 3 2 
Other 3 3 2 
Fisher’s exact test p-value: ~1 
 No significant relationship between ethnicity and MMAS scores. 
Table 2. MMAS Scores by Gender: Number of Respondents with High, Medium, 
and Low Scores 
Gender High Score (8) Med Score (6–7) Low Score (<5) 
Female 7 6 7 
Male 1 3 0 
Fisher’s exact test p-value: 0.336  
No significant relationship between gender and MMAS scores. 
Table 3. MMAS Scores and Age 
Group Df SumSq Mean Sq Fvalue Pr(>F) 
MMAS Group 2 22.712 11.3562 3.7682 0.03996 
Residuals 21 63.288 3.0137   
 High MMAS Score Med MMAS Score Low MMAS Score 
Mean Age 16.88 14.78 14.86 
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CHAPTER 5: DISCUSSION 
Adherence to recommended treatments is of great importance in JA and 
other chronic rheumatologic diseases. The effects of medication adherence are 
directly related to disease outcome, quality of life and prognosis (Pelajo, et al., 
2012). Adherence to certain medications, such as methotrexate, is widely used in 
pediatric rheumatology. It is therefore important to differentiate lack of therapeutic 
efficacy of prescribed medications versus non-adherence to these medications. 
In this pilot study, based on responses to the MMAS surveys, the majority 
of responses (93%) were “yes” to Question 1, “Do you sometimes forget to take 
your pills.” Based on the results of this pilot study, forgetfulness is the common 
reason for medication non-adherence. Forgetfulness is also a common thread, 
based on studies for medication non-adherence in school-age children (Feldman et 
al., 2007; Rapoff et al., 2002; Rapoff & Lindsley, 2006). In our study, results of 
medication non-adherence did not relate to gender, ethnicity, or years diagnosed 
with JA. However, there was a statistical relationship between age and adherence 
to prescribed medications. Older patients (age > 15 years) were more likely to be 
adherent than younger children (ages < 14 years). This may be due to growing 
autonomy or maturity.  
Adherence rates to JA treatment vary widely, depending on the study, and 
on the method used to assess adherence. In general, more objective measures (such 
as electronic monitoring) show lower adherence rates of adherence than self-
reports (Rapoff et al., 2002). Subjects tend to respond more favorably towards 
adherence when surveyed or questioned by researchers or their health care 
providers (April et al., 2006).  
The results of this pilot study should be interpreted with several limitations 
in mind. First, surveys were conducted for subjects who regularly attended their 
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outpatient appointments. Therefore, survey participants may have been more 
likely to comply with their medications and treatment plan than average patients. 
Additionally, this study only surveyed older, English-speaking children, between 
the ages of 11–17. The sample size was also small (n=26) affecting the statistical 
significance of our results. Subjects surveyed were also asked after speaking with 
the physician, so there may have been a self-reported underestimation of 
medication non-adherence. Studies have shown that subjects tend to answer more 
favorably when research instrumentations of surveys or questionnaires are 
involved.  
The manner in which surveys and questionnaires were collected also played 
a role in the answers of the participants. The investigators were in the room when 
the participants were completing the surveys. Parents, or care-providers, were also 
in the rooms with their child, which may have also influenced the subjects 
answered. Based on these limitations, subjects may have answered their responses 
more favorably towards adherence.  
In the subjective portions of the open-ended questionnaires collected, 
knowledge of their medication varied. Those who filled out their open-ended 
questionnaires with understanding of what their medication, and who were older 
(over the age of 14 years of age) were most likely to have a higher MMAS score. 
However, knowledge of their medication did not correlate to a higher medication 
score, based on the results of the open-ended questionnaire. The subjects who had 
the highest medication adherence score (MMAS = 8) had low knowledge of their 
medication’s action. Those subjects who scored low or moderate adherence scores 
(MMAS = 1-7) had appropriate knowledge of their medication’s action.  
The validity and reliability of the MMAS survey and the open-ended 
questionnaire were not tested. The MMAS survey had been previously researched 
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and tested with adult patients, but not with pediatric patients; therefore we cannot 
conclude the same results with children as we can with adults. The open-ended 
questionnaire had not been tested in any study. It was formulated specifically for 
this pilot study, in order to assess patient’s knowledge of their medication. 
Therefore, we cannot assume the reliability of this open-ended questionnaire. 
Also, the timing of when the survey was administered also plays a role in the 
responses of the subjects surveyed. They were surveyed after meeting with their 
physician. Therefore, they may have received the response to the question asked 
on “what their medication does” after meeting with their health care provider.  
Subjects speaking other languages, besides English, were not included in 
this study. Language barriers and low health literacy constitute additional 
obstacles to medication adherence that this study did not measure. The use of an 
interpreter and translation of the surveys in other languages would have influenced 
the results of this study. Results of this study may have varied, if we had included 
those patients for whom English was not the primary language spoken at home.  
The limitations in this study can direct future studies in pediatric 
medication non-adherence. There has already been research in pediatric 
medication non-adherence among children with chronic disorders such as asthma, 
diabetes, cystic fibrosis, and epilepsy (Costello, Wong & Nunn, 2004; Gardiner & 
Dvorkin, 2006). Formation of an accepted medication adherence scale written for 
pediatrics is an area of future study.  
Lack of knowledge of their medication is not the only barrier to teens 
adhering to their medication. There are other extraneous factors that influence a 
child’s adherence to their medication, but first we need to develop a tool that 
measures a child’s medication adherence. From there we can then begin to identify 
specific factors as to why certain pediatric patients do not adhere to their 
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medication. Once we can uncover the true reasons from the child or patients 
themselves, can we begin to identify the solutions. 
Recommendations for Pediatric Medication Non-
Adherence 
One solution to increase medication adherence and understanding is the 
Teach Back Method. This method is an educational tool where the provider 
educates the patient on their medication. This method then requires the patient to 
state back, in their own words what they have learned from the provider’s 
education. Essentially, “teaching back” what was taught to them. This tool has 
been studied and utilized in the past decade in clinics and acute settings, primarily 
with residents. Now, we see research and evidence that this method of patient 
education is successful in increasing patient knowledge of their health routine.  
Possible solutions to increase medication adherence, specifically to JA, is 
adherence-enhancement strategies. Rapoff et al. (2002) suggested the following 
strategies for enhancing adherence: cueing (paring medication with an established 
behavior such as brushing one’s teeth), monitoring (using a calendar to track when 
medication is taken) positive reinforcement (praising and rewarding with special 
tokens when medication is correctly taken) and discipline (using time-out for 
defiant refusals to take one’s medication). 
Other possible ways to increase medication adherence include simplifying 
the medication regimen (taking one pill per day, as opposed to four pills 
throughout the day), decreasing cost, clear explanation of how medication should 
be taken and why, consideration of patient needs and lifestyle with medication 
treatment, and follow-up on how their medication is working and if changes or 
further education needs to be done.  
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To date, measuring patient medication adherence and using interventions to 
improve adherence are uncommon practices in routine clinical care and acute care 
settings. For this reason, medication adherence has been called the “next frontier 
in quality improvement” and is an important aspect of patient heath care and 
initiatives (Heidenrich, 2004). Therefore, it is imperative to continue to study the 
reasons for medication non-adherence. Once we find the reasons, can we then 
begin to identify and research solutions to remedy this preventable health care 
problem.
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APPENDIX A: CONSENT FORM 
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APPENDIX C: MMAS SURVEY 
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8.  How often do you have difficulty remembering to take all your 
medications?   (Please circle your response below)  
Never/Rarely……………………………………...4  
Once in a while……………………………………3 
Sometimes………………………………………...2  
Usually…………………………………………….1  
All the time………………………………………..0  
 
 
Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A 
license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, 
Department of Community Health Sciences, UCLA School of Public Health, 650 
Charles E. Young Drive South, Los Angeles, CA 90095-1772.  
©Morisky Medication Adherence Scale (MMAS-8-Item). This is a 
generic adherence scale and the name of the health concern can be 
substituted in each question item.      
You indicated that you are taking medication for your (identify health concern, such as 
“high blood pressure”).  Individuals have identified several issues regarding their 
medication-taking behavior and we are interested in your experiences.  There is no 
right or wrong answer.  Please answer each question based on your personal 
experience with your [health concern] medication.    
                                                                              (Please check your response below)  
   No=1  Yes=0  
1.  Do you sometimes forget to take your pills?       
2.  People sometimes miss taking their medications for reasons other 
than forgetting. Thinking over the past two weeks, were there any 




   
3. Have you ever cut back or stopped taking your medication without 
telling your doctor, because you felt worse when you took it?  
     
4. When you travel or to school, do you sometimes forget to bring 
along your medication?   
    
5. Did you take your medicine yesterday?       
6. When you feel like your is under control, do you sometimes stop 
taking your medicine? 
     
7. Taking medication is a real inconvenience for some people. Do 
you sometimes feel hassled by your medication routine?   
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Open-Ended Questionnaire 
By answering this survey, you have given consent to participate in this study.  
This survey is completely anonymous. Please do not include your name, or any other 
information that may identify you other than the items listed below.  
  
How old are you? ______  
Please Circle:   Male      or   Female   






Years diagnosed with juvenile arthritis _____________________  
 
1. Do you feel that your medication helps you with your pain? Yes or No  
  
2. Do you understand what your arthritis medication does to help with your arthritis 
symptoms? Yes or No  
  





4. Besides taking your medicine, what do you do that helps you with your juvenile 
arthritis?   
Fill in your answer:__________________________________________  
